Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Walter Bagehot who wrote (38118)	5/31/2010 10:05:01 PM
From: Jurgis Bekepuris	Respond to of 78954

Walter, IMHO, Buffett's investments are much less interesting now than they were 10-15 years ago. Especially last year he has been more driven by getting cash for his non-stock (preferred) and Burlington Northern investments than by buying stock positions. One could argue that in such situation his buys, holds and sells are even more meaningful, but I don't think so. I think he sells what he can easily sell (COP, PG, JNJ) and sometimes things that are small positions that are not very good/important (UNH, WLP, TRV, KMX, GCI, STI). IMHO, the only big sell statement he made this quarter was KFT sale that he publicly said he won't do. Maybe there is some deep thinking behind healthcare position sales although he also bought BDX in this area. And I'd guess it does not go much further than the possible negative impacts of healthcare reform. On the buy side BDX has been discussed on this thread already. It is somewhat attractive. The other two buys - IRM and RSG - are not interesting/attractive to me. BAC has been a small position for a long time now. Buffett has not increased or decreased it through the crisis. I would not read much into its existence. From Buffett stocks, I personally hold only a position in JNJ. I thought it was somewhat attractively priced, but then the current scandal broke out. Not sure I'd buy it here. :(